These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6798501)

  • 1. Surgical considerations in melanoma: staging, excision, and prognostic factors.
    Seyfer AE; Seab JA
    Mil Med; 1981 Nov; 146(11):785-7. PubMed ID: 6798501
    [No Abstract]   [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy: is it an evolution of the management of cutaneous melanoma?
    De Giorgi V; Grazzini M; Papi F; Gori A; Rossari S; Lotti T
    Ann Surg Oncol; 2011 Feb; 18(2):597; author reply 598-9. PubMed ID: 20411434
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant melanoma: primary surgical management (excision and node dissection) based upon pathology and staging.
    Evans RA
    Cancer; 1995 Dec; 76(11):2384-5. PubMed ID: 8635048
    [No Abstract]   [Full Text] [Related]  

  • 4. A glimpse of future management of melanoma.
    Cochran AJ
    Arch Dermatol; 2009 Oct; 145(10):1176-7. PubMed ID: 19841407
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of surgery in cutaneous malignant melanoma.
    Coit DG
    Cancer Treat Res; 1993; 65():297-334. PubMed ID: 8104026
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
    Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors associated with local and in-transit recurrence of cutaneous melanoma.
    Stucky CC; Gray RJ; Dueck AC; Wasif N; Laman SD; Sekulic A; Pockaj BA
    Am J Surg; 2010 Dec; 200(6):770-4; discussion 774-5. PubMed ID: 21146019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases.
    Mocellin S; Pasquali S; Rossi CR; Nitti D
    Surgery; 2011 Jul; 150(1):83-90. PubMed ID: 21683860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
    Leiter U; Buettner PG; Bohnenberger K; Eigentler T; Meier F; Moehrle M; Breuninger H; Garbe C
    Ann Surg Oncol; 2010 Jan; 17(1):129-37. PubMed ID: 19866238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extent of lymph node clearance required in stage III-B melanoma].
    Avril MF
    Ann Dermatol Venereol; 2008 Feb; 135(2):91-2. PubMed ID: 18342087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of variations between surgeons regarding inguinal lymph node clearance in melanoma].
    Danino MA; Trost O; Malka G; Garrido I; Jebrane A; Dalac S
    Ann Dermatol Venereol; 2008 Feb; 135(2):142-4. PubMed ID: 18342100
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional nodal surgery for melanoma impacts recurrence rates and survival.
    Reintgen DS
    Ann Surg Oncol; 2000 Mar; 7(2):80-1. PubMed ID: 10761783
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical treatment of malignant melanoma: practical guidelines.
    Levine SM; Shapiro RL
    Dermatol Clin; 2012 Jul; 30(3):487-501. PubMed ID: 22800553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant skin melanoma].
    Drzewiecki KT; von der Maase H
    Ugeskr Laeger; 2002 Jun; 164(23):3031-5. PubMed ID: 12082854
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stage-dependent surgical resection of malignant melanoma].
    Karakousis C
    Chirurg; 1994 Mar; 65(3):164-74. PubMed ID: 8194400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.